OOIR: Observatory of International Research

Papers

(The TQCC of Stem Cell Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Neutralizing antibodies targeting SARS-CoV-2 spike protein	86
Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson’s disease	64
Furin cleavage sites naturally occur in coronaviruses	57
Strategies for scalable manufacturing and translation of MSC-derived extracellular vesicles	53
Human mesenchymal stem cells promote ischemic repairment and angiogenesis of diabetic foot through exosome miRNA-21-5p	52
Human mesenchymal stem cell therapy for cartilage repair: Review on isolation, expansion, and constructs	50
Sex-specific differences in transcriptomic profiles and cellular characteristics of oligodendrocyte precursor cells	31
Methadone interrupts neural growth and function in human cortical organoids	30
Haplobanking induced pluripotent stem cells for clinical use	30
Generation of pure monocultures of human microglia-like cells from induced pluripotent stem cells	27
Development and implementation of large-scale quality control for the European bank for induced Pluripotent Stem Cells	26
SARS-CoV-2 infection and stem cells: Interaction and intervention	26
Extracellular vesicles released by adipose tissue-derived mesenchymal stromal/stem cells from obese pigs fail to repair the injured kidney	25
Characterization and application of electrically active neuronal networks established from human induced pluripotent stem cell-derived neural progenitor cells for neurotoxicity evaluation	25
Exosomes from 3D culture of marrow stem cells enhances endothelial cell proliferation, migration, and angiogenesis via activation of the HMGB1/AKT pathway	21
A safety consideration of mesenchymal stem cell therapy on COVID-19	21
Hypoxia/Hif1α prevents premature neuronal differentiation of neural stem cells through the activation of Hes1	21
Functional and molecular effects of TNF-α on human iPSC-derived cardiomyocytes	20
The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries	20
NODAL inhibition promotes differentiation of pacemaker-like cardiomyocytes from human induced pluripotent stem cells	19
Treadmill training improves survival and differentiation of transplanted neural precursor cells after cervical spinal cord injury	19
In vivo regeneration of rat laryngeal cartilage with mesenchymal stem cells derived from human induced pluripotent stem cells via neural crest cells	19
Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming	18
Establishment of human induced trophoblast stem-like cells from term villous cytotrophoblasts	18
Transplantation of iPSC-derived corneal endothelial substitutes in a monkey corneal edema model	18

Human corneal limbal organoids maintaining limbal stem cell niche function	17
Sex-dependent immune response and lethality of COVID-19	17
Non-permissive SARS-CoV-2 infection in human neurospheres	17
Extrinsic modulation of integrin α6 and progenitor cell behavior in mesenchymal stem cells	17
CiRA iPSC seed stocks (CiRA's iPSC Stock Project)	16
Eyes on coronavirus	16
Rapid generation of regionally specified CNS neurons by sequential patterning and conversion of human induced pluripotent stem cells	16
Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control	16
Slug-expressing mouse prostate epithelial cells have increased stem cell potential	16
The Global Alliance for iPSC Therapies (GAiT)	16
Generation of twenty four induced pluripotent stem cell lines from twenty four members of the Lothian Birth Cohort 1936	16
Generation of two gene edited iPSC-lines carrying a DOX-inducible NGN2 expression cassette with and without GFP in the AAVS1 locus	15
Efficacy of combination therapy with pentosan polysulfate sodium and adipose tissue-derived stem cells for the management of interstitial cystitis in a rat model	15
Matrigel is required for efficient differentiation of isolated, stem cell-derived otic vesicles into inner ear organoids	15
Feeder-free generation and transcriptome characterization of functional mesenchymal stromal cells from human pluripotent stem cells	14
Cancer stem cell markers for liver cancer and pancreatic cancer	14
Access to stem cell data and registration of pluripotent cell lines: The Human Pluripotent Stem Cell Registry (hPSCreg)	14
Ocular surface ectoderm instigated by WNT inhibition and BMP4	13
Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery	13
Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation	13
Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system	12
Effect of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on reproductive system	12
Adipose-derived stromal vascular fraction (SVF) cells for the treatment of non-reconstructable peripheral vascular disease in patients with critical limb ischemia: A 6-year follow-up showing durable e	12
The primary cilium directs osteopontin-induced migration of mesenchymal stem cells by regulating CD44 signaling and Cdc42 activation	12
Generation of a human iPSC line, FINCBi001-A, carrying a homoplasmic m.G3460A mutation in MT-ND1 associated with Leber’s Hereditary optic Neuropathy (LHON)	12
IL-11 and soluble VCAM-1 are important components of Hypoxia Conditioned Media and crucial for Mesenchymal Stromal Cells attraction	12
Cardiac fibrosis models using human induced pluripotent stem cell-derived cardiac tissues allow anti-fibrotic drug screening in vitro	12
Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population	12
Generation of striatal neurons from human induced pluripotent stem cells by controlling extrinsic signals with small molecules	12
GMP Banking of Human Pluripotent Stem Cells: A US and UK perspective	12
Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis	12
In vitro differentiation of pluripotent stem cells into hepatocyte like cells – Basic principles and current progress	11
Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells	11
Generation of an induced pluripotent stem cell line (UNCCi002-A) from a healthy donor using a non-integration system to study Cerebral Cavernous Malformation (CCM)	11
MicroRNAs and Ascl1 facilitate direct conversion of porcine fibroblasts into induced neurons	11
Korea National Stem Cell Bank	11
SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells	11
Multiomics analyses of cytokines, genes, miRNA, and regulatory networks in human mesenchymal stem cells expanded in stirred microcarrier-spinner cultures	11
Self-assembling 3D spheroid cultures of human neonatal keratinocytes have enhanced regenerative properties	11
Generation and characterization of iPSC lines (BGUi004-A, BGUi005-A) from two identical twins with polyalanine expansion in the paired-like homeobox 2B (PHOX2B) gene	11
Culture of rabbit caecum organoids by reconstituting the intestinal stem cell niche in vitro with pharmacological inhibitors or L-WRN conditioned medium	11
LINC00473 regulated apoptosis, proliferation and migration but could not reverse cell cycle arrest of human bone marrow mesenchymal stem cells induced by a high-dosage of dexamethasone	11
Generation and proteome profiling of PBMC-originated, iPSC-derived lentoid bodies	11
Generation of iPSC lines from two patients affected by febrile seizure due to inherited missense mutation in SCN1A gene	11
Quantitative analysis of mitochondrial morphologies in human induced pluripotent stem cells for Leigh syndrome	10
Karolinska Institutet Human Embryonic Stem Cell Bank	10
Differential regulation of lineage commitment in human and mouse primed pluripotent stem cells by the nucleosome remodelling and deacetylation complex	10
Modeling cancer progression using human pluripotent stem cell-derived cells and organoids	10
Generation of pluripotent stem cell lines and CRISPR/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutation	10
Establishment of novel common marmoset embryonic stem cell lines under various conditions	10

Decoding molecular markers and transcriptional circuitry of naive and primed states of human pluripotency	10
Advances in human mesenchymal stromal cell-based therapies – Towards an integrated biological and engineering approach	10
Genomic integrity of human induced pluripotent stem cells across nine studies in the NHLBI NextGen program	10
Generation of an integration-free induced pluripotent stem cell line (UNC001-A) from blood of a healthy individual	10
Blebbistatin protects iPSC-CMs from hypercontraction and facilitates automated patch-clamp based electrophysiological study	10
Polyvinyl alcohol hydrolysis rate and molecular weight influence human and murine HSC activity ex vivo	10
Mesenchymal stem cells modulate misfolded α-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy	10
Isolation of PRRX1-positive adult pituitary stem/progenitor cells from the marginal cell layer of the mouse anterior lobe	10
Pluripotent pig embryonic stem cell lines originating from in vitro-fertilized and parthenogenetic embryos	9
The EBiSC iPSC bank for disease studies	9
Generation of human pluripotent stem cell lines (iPSCs) from mesenchymal stem cells (MSCs) from three elderly patients with osteoarthritis	9
Medical progress: Stem cells as a new therapeutic strategy for COVID-19	9
EphA7+ perivascular cells as myogenic and angiogenic precursors improving skeletal muscle regeneration in a muscular dystrophic mouse model	9
Generation of a male common marmoset embryonic stem cell line DSY127-BV8VT1 carrying double reporters specific for the germ cell linage using the CRISPR-Cas9 and PiggyBac transposase systems	9
Adaptation of the AID system for stem cell and transgenic mouse research	9
LncRNA Mrhl orchestrates differentiation programs in mouse embryonic stem cells through chromatin mediated regulation	9
Control of mesenchymal cell fate via application of FGF-8b in vitro	9
DLL4 restores damaged liver by enhancing hBMSC differentiation into cholangiocytes	8
Development of a fully human assay combining NGN2-inducible neurons co-cultured with iPSC-derived astrocytes amenable for electrophysiological studies	8
SIRT1 induces the adipogenic differentiation of mouse embryonic stem cells by regulating RA-induced RAR expression via NCOR1 acetylation	8
Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control	8
L1cam curbs the differentiation of adult-born hippocampal neurons	8
Induced pluripotent stem cell line UOMi002-A from a patient with Leigh syndrome with compound heterozygous mutations in the NDUFV1 gene	8
Systematic assessment of variability in the proteome of iPSC derivatives	8
Distinct molecular profile and restricted stem cell potential defines the prospective human cranial neural crest from embryonic stem cell state	8
Patient-specific iPSC-derived cellular models of LGMDR1	8
Electrophysiological evaluation of human induced pluripotent stem cell-derived cardiomyocytes obtained by different methods	8
p57 is a master regulator of human adipose derived stem cell quiescence and senescence	8
Generation of urine-derived iPS cell line via a non-integrative method from a Barth syndrome patient with TAZ gene mutation	8
Reliable generation of glial enriched progenitors from human fibroblast-derived iPSCs	8
Non-viral derivation of a transgene-free induced pluripotent stem cell line from a male beagle dog	8
Establishment and characterization of two iPSC lines derived from healthy controls	8
Generation of disease-specific and CRISPR/Cas9-mediated gene-corrected iPS cells from a patient with adult progeria Werner syndrome	8
Generation of fourteen isogenic cell lines for Parkinson’s disease-associated leucine-rich repeat kinase (LRRK2)	8
Human-induced pluripotent stem cell lines (CMCi006-A and CMCi007-A) from a female and male patient with Fabry disease carrying the same frameshift deletion mutation	8
Generation of multiple iPSC clones from a male schizophrenia patient carrying de novo mutations in genes KHSRP, LRRC7, and KIR2DL1, and his parents	7
Generation and genetic repair of two human induced pluripotent cell lines from patients with Epidermolysis Bullosa simplex and dilated cardiomyopathy associated with a heterozygous mutation in the tra	7
CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A	7
Modeling leukemia with pediatric acute leukemia patient-derived iPSCs	7
Generation of iPSC line (USTCi001-A) from human skin fibroblasts of a patient with epilepsy	7
PI3K-Akt signaling regulates BMP2-induced osteogenic differentiation of mesenchymal stem cells (MSCs): A transcriptomic landscape analysis	7
Derivation of stem cell line UMi028-A-2 containing a CRISPR/Cas9 induced Alzheimer’s disease risk variant p.S1038C in the TTC3 gene	7
Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing	7
Generation of induced pluripotent stem cell line RCPCMi008-A derived from patient with spinocerebellar ataxia 17	7
Generation of a human iPSC line from an epileptic encephalopathy patient with electrical status epilepticus during sleep carrying KCNA2 (p.P405L) mutation	7
Endothelial cell secreted VEGF-C enhances NSC VEGFR3 expression and promotes NSC survival	7
Generation of a human induced pluripotent stem cell line (CPGHi001-A) from a hearing loss patient with the TMC1 p.M418K mutation	7
Generation of two hiPSC clones (MHHi019-A, MHHi019-B) from a primary ciliary dyskinesia patient carrying a homozygous deletion in the NME5 gene (c.415delA (p.Ile139Tyrfs*8))	7
Structural insights into SARS-CoV-2 infection and therapeutics development	7
Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutatio	7
Transcription factor overexpression drives reliable differentiation of retinal pigment epithelium from human induced pluripotent stem cells	7
Generation of human induced pluripotent stem cells (SDUKIi002-A) from a 22-year-old male diagnosed with autism spectrum disorder	7
Generation of integration-free induced pluripotent stem cell lines from four pediatric ADHD patients	7
Donor-derived vasculature is required to support neocortical cell grafts after stroke	7
Generation of induced pluripotent stem cell line RCPCMi004-A derived from patient with Parkinson's disease with deletion of the exon 2 in PARK2 gene	7
Lgr5 maintains stemness and regulates cell property in nasopharyngeal carcinoma through Wnt/β-catenin signaling pathway	7
Cellular reprogramming to model and study epigenetic alterations in cancer	7
Modeling of early neural development in vitro by direct neurosphere formation culture of chimpanzee induced pluripotent stem cells	7
ATM modulates subventricular zone neural stem cell maintenance and senescence through Notch signaling pathway	7
Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins Syndrome	7
Restorative effect of adipose tissue-derived stem cells on impaired hepatocytes through Notch signaling in non-alcoholic steatohepatitis mice	6
Generation of an induced pluripotent stem cell line from a congenital microtia patient with 4p16.1 microduplication involving the long-range enhancer of HMX1	6
Derivation of a human induced pluripotent stem cell line (QBRIi007-A) from a patient carrying a homozygous intronic mutation (c.613-7T>G) in the SLC2A2 gene	6
Generation of induced pluripotent stem cell line, ICGi034-A, by reprogramming peripheral blood mononuclear cells from a patient with Parkinson’s disease associated with GBA mutation	6
Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines	6
TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells	6
Derivation of three induced pluripotent stem cell lines under feeder-free culture conditions from peripheral blood mononuclear cells (PBMC) of Indian patients suffering from inherited retinal diseases	6
Generation of a gene edited hemophilia A patient-derived iPSC cell line, YCMi001-B-1, by targeted insertion of coagulation factor FVIII using CRISPR/Cas9	6
Generation of a heterozygous GAPDH-Luciferase human ESC line (HVRDe008-A-1) for in vivo monitoring of stem cells and their differentiated progeny	6
Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant	6
Generation of induced pluripotent stem cell line (CSUXHi002-A) from a patient with spinocerebellar ataxia type 1	6
Generation of pathogenic TPP1 mutations in human stem cells as a model for neuronal ceroid lipofuscinosis type 2 disease	6
Cdkn1a deletion or suppression by cyclic stretch enhance the osteogenic potential of bone marrow mesenchymal stem cell-derived cultures	6
Adult kidney stem/progenitor cells contribute to regeneration through the secretion of trophic factors	6
Generation of an INSULIN-H2B-Cherry reporter human iPSC line	6
Inhibition of focal adhesion kinase increases adult olfactory stem cell self-renewal and neuroregeneration through ciliary neurotrophic factor	6
Generation of integration-free induced pluripotent stem cells from healthy individuals	6
Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing	6
The International Stem Cell Banking Initiative (ISCBI)	6
Human pluripotent stem cell line (HDZi001-A) derived from a patient carrying the ARVC-5 associated mutation TMEM43-p.S358L	6

Generation of clinical-grade human embryonic stem cell line KthES11 according to Japanese regulations	6
Generation of six human iPSC lines from patients with a familial Alzheimer’s disease (n = 3) and sex- and age-matched healthy controls (n = 3)	6
Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation	6
Calreticulin regulates Src kinase in osteogenic differentiation from embryonic stem cells	6
Superoxide dismutase and catalase significantly improve the osteogenic differentiation potential of osteogenetically compromised human adipose tissue-derived stromal cells in vitro	6
Extracellular laminin regulates hematopoietic potential of pluripotent stem cells through integrin β1-ILK-β-catenin-JUN axis	6
Corrigendum to “Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line” [Stem Cell Res. 34/1873–5061 (2019) 101349–55]	6
Generation of an induced pluripotent stem cell line from an Alström Syndrome patient with ALMS1 mutation (c.3902C > A, c.6436C > T) and a gene correction isogenic iPSC line	6
Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene	6
Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine	6
Derivation of two naturally isogenic iPSC lines (KAUSTi006-A and KAUSTi006-B) from a mosaic Klinefelter Syndrome patient (47-XXY/46-XY)	6
Generation of a double insulin and somatostatin reporter line, SCSe001-A-3, for the advancement of stem cell-derived pancreatic islets	5
Generation of a human induced pluripotent stem cell line (CPGHi003-A) from an auditory neuropathy patient with AIFM1 p.R422Q mutation	5
Divergent roles for KLF4 and TFCP2L1 in naive ground state pluripotency and human primordial germ cell development	5
Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation	5
Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35	5
Generation of an induced pluripotent stem cell line from chorionic villi of a Patau syndrome spontaneous abortion	5
Generation of an ALS human iPSC line KEIOi001-A from peripheral blood of a Charcot disease-affected patient carrying TARDBP p.N345K heterozygous SNP mutation	5
Generation of two induced pluripotent stem cell lines IMAGINi004-A and IMAGINi005-A from healthy donors	5
In vitro expansion of cirrhosis derived liver epithelial cells with defined small molecules	5
Generation and characterization of human induced pluripotent stem cells (iPSCs) from three male and three female patients with CDKL5 Deficiency Disorder (CDD)	5
Generation of two induced pluripotent stem cell (iPSC) lines from patients with Duchenne muscular dystrophy (IGIBi006-A and IGIBi008-A) carrying exonic deletions in the dystrophin gene	5
The CIRM iPSC repository	5
Generation of two induced pluripotent stem cell lines with heterozygous and homozygous GAG deletion in TOR1A gene from a healthy hiPSC line	5
Generation of human iPSC line (UCLi013-A) from a patient with microphthalmia and aniridia, carrying a heterozygous missense mutation c.372C>A p.(Asn124Lys) in PAX6	5
Generation of two induced pluripotent stem cell (iPSC) lines (BBANTWi006-A, BBANTWi007-A) from Brugada syndrome patients carrying an SCN5A mutation	5
Generation and characterization of four Chediak-Higashi Syndrome (CHS) induced pluripotent stem cell (iPSC) lines	5
Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation	5
The fate of human SUSD2+ endometrial mesenchymal stem cells during decidualization	5
An iPSC line derived from a human acute myeloid leukemia cell line (HL-60-iPSC) retains leukemic abnormalities and displays myeloid differentiation defects	5
Establishment of iPSC lines from a high-grade Klinefelter Syndrome patient (49-XXXXY) and two genetically matched healthy relatives (KAUSTi003-A, KAUSTi004-A, KAUSTi004-B, KAUSTi005-A, KAUSTi005-B, KA	5
Metabolic maturation of differentiating cardiosphere-derived cells	5
Generation of a Friedreich’s Ataxia patient-derived iPSC line USFi001-A	5
Generation of a GPR146 knockout human induced pluripotent stem cell line (ITXi001-A-1)	5
Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson’s disease patient carrying the heterozygous p.A30P mutation in SNCA	5
Generation of a human induced pluripotent stem cell line (CMCi002-A) from a patient with Gitelman’s syndrome	5
Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy	5
A kainic acid-induced seizure model in human pluripotent stem cell-derived cortical neurons for studying the role of IL-6 in the functional activity	5
Generation of two human induced pluripotent stem cell lines derived from myoblasts (MDCi014-A) and from peripheral blood mononuclear cells (MDCi014-B) from the same donor	5
Effect of initial seeding density on cell behavior-driven epigenetic memory and preferential lineage differentiation of human iPSCs	5
Generation of induced pluripotent stem cell line (ZZUi0018-A ) from a patient with spinocerebellar ataxia type 6	5
Generation of two human control iPS cell lines (UCLi016-A and UCLi017-A) from healthy donors with no known ocular conditions	5
Branched-chain amino acid aminotransferase-1 regulates self-renewal and pluripotency of mouse embryonic stem cells through Ras signaling	5
Generation of two patient-derived iPSC lines from siblings (LIBUCi001-A and LIBUCi002-A) and a genetically modified iPSC line (JMUi001-A-1) to mimic dilated cardiomyopathy with ataxia (DCMA) caused by	5
Establishment of human induced pluripotent stem cells derived from skin cells of a patient with Dravet syndrome	5
Peripheral sensory neurons promote angiogenesis in neurovascular models derived from hESCs	5
A quantitative hematopoietic stem cell reconstitution protocol: Accounting for recipient variability, tissue distribution and cell half-lives	5
Transient receptor potential vanilloid 2 mediates the inhibitory effect of far-infrared irradiation on adipogenic differentiation of tonsil-derived mesenchymal stem cells	5
Generation of pulmonary arterial hypertension patient-specific induced pluripotent stem cell lines from three unrelated patients with a heterozygous missense mutation in exon 12, a heterozygous in-fra	5
Generation of two human iPSC lines from patients with maturity-onset diabetes of the young type 2 (MODY2) and permanent neonatal diabetes due to mutations in the GCK gene	5
Establishment of an iPSC line (JTUi002-A) from a patient with Waardenburg syndrome caused by a SOX10 mutation and carrying a GJB2 mutation	5
Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer’s disease	5
Generation and genetic repair of 2 iPSC clones from a patient bearing a heterozygous c.1120del18 mutation in the ACVRL1 gene leading to Hereditary Hemorrhagic Telangiectasia (HHT) type 2	5
Generation of a human induced pluripotent stem cell line PUMCi001-A from a patient with Krabbe disease	5
Generation of two human induced pluripotent stem cell lines derived from two juvenile nephronophthisis patients with NPHP1 deletion	5
Generation of a TPM1 homozygous knockout embryonic stem cell line by CRISPR/Cas9 editing	5
Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease	5
Establishment of an induced pluripotent stem cell line from a female domestic ferret (Mustela putorius furo) with an X chromosome instability	5
A critical review on induced totipotent stem cells: Types and methods	5
Modeling of osteosarcoma with induced pluripotent stem cells	5
Establishment and characterization of induced pluripotent stem cell line (IGIBi002-A) from a β-thalassemia patient with IVS1-5 mutation by non-integrating reprogramming approach	5
Generation of two induced pluripotent stem cell lines (XACHi0010-A, XACHi0011-A) from a Chinese family with combined oxidative phosphorylation deficiency carrying homozygous and heterozygous C1QBP-L27	5
Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing	4
Generation and characterization of iPSC lines (UOHi003-A, UOHi002-A) from a patient with SHANK3 mutation and her healthy mother	4
Generation of four postmortem dura-derived iPS cell lines from four control individuals with genotypic and brain-region-specific transcriptomic data available through the BrainSEQ consortium.	4
Human induced pluripotent stem cells generated from a patient with a homozygous L272P mutation in the OTULIN gene (NIHTVBi014-A)	4
Generation of patient-specific induced pluripotent stem cell line (CSUi002-A) from a patient with isolated dystonia carrying TOR1A mutation	4
Generation of a homozygous knock-in human embryonic stem cell line expressing SNAP-tagged SOD1	4
Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9	4
Establishment of MHHi001-A-5, a GCaMP6f and RedStar dual reporter human iPSC line for in vitro and in vivo characterization and in situ tracing of iPSC derivatives	4
Generation of a human induced pluripotent stem cell line from a Bietti crystalline corneoretinal dystrophy patient with CYP4V2 mutations	4
Chromatin accessibility profiling identifies evolutionary conserved loci in activated human satellite cells	4
Establishment of a novel human iPSC line (SDQLCHi032-A) derived from a patient with primary hypertrophic osteoarthropathy caused by HPGD homozygous mutation	4
Generation of human induced pluripotent stem cells (hIPSCs) from sialidosis types I and II patients with pathogenic neuraminidase 1 mutations	4
Establishment of two induced pluripotent stem cell line from healthy elderly (IPTi005-A and IPTi007-A)	4
Generation of induced pluripotent stem cell Line KAIMRCi001-A by reprogramming erythroid progenitors from peripheral blood of a healthy Saudi donor	4
A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy	4
Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency	4
Human iPSC-derived neural crest stem cells can produce EPO and induce erythropoiesis in anemic mice	4
Generation of induced pluripotent stem cell GZHMCi001-A and GZHMCi001-B derived from peripheral blood mononuclear cells of epileptic patients with KCNC1 mutation	4
Hypoxia depletes contaminating CD45+ hematopoietic cells from murine bone marrow stromal cell (BMSC) cultures: Methods for BMSC culture purification	4
Generation of an iPSC line (UNINAi001-A) from a girl with neonatal-onset epilepsy and non-syndromic intellectual disability carrying the homozygous KCNQ3 p.PHE534ILEfs*15 variant and of an iPSC line (	4
Generation of a CRISPR/Cas edited human induced pluripotent stem cell line DHMi005-A-1 carrying a patient-specific disease-causing point mutation in the TBX5 gene	4
Derivation of iPSC line (RCMGi002-A) from dermal fibroblasts of a cystic fibrosis female patient with homozygous F508del mutation	4
Mesenchymal stem cells and prostate cancer: A concise review of therapeutic potentials and biological aspects	4
Generation of two human induced pluripotent stem cell lines (MHHi017-A, MHHi017-B) from a patient with primary ciliary dyskinesia carrying a homozygous mutation (c.7915C > T [p.Arg2639*]) in the DN	4
Repair of acute liver damage with immune evasive hESC derived hepato-blasts	4
Generation of Dip2a homozygous knockout murine ES cell line IBMSe001-A-1 via CRISPR/Cas9 technology	4
Establishment of an arrhythmogenic right ventricular cardiomyopathy derived iPSC cell line (USFi004-A) carrying a heterozygous mutation in PKP2 (c.1799delA)	4
Establishment of an induced pluripotent stem (iPS) cell line (SDUKIi006-A) from a 21-year old male patient diagnosed with atypical autism disorder	4
Generation of three age and gender matched pairs of human induced pluripotent stem cells derived from myoblasts (MDCi011-A, MDCi012-A, MDCi013-A) and from peripheral blood mononuclear cells (MDCi011-B	4
Generation of two human NRF2 knockout iPSC clones using CRISPR/Cas9 editing	4
Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing	4
Generation of human induced pluripotent stem cell lines from 2 patients with MIRAGE syndrome	4
Generation and characterization of a novel human iPSC line from a resilient Alzheimer’s disease patient	4